Eray Ontas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eray Ontas has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Onur Özalp
Eskişehir Osmangazi University, Faculty of Medicine, Department of Ophthalmology, Eskişehir, Türkiye
2 shared publications - Akif Turna
Department of Thoracic Surgery, Cerrahpasa Medical Faculty, İstanbul University-Cerrahpasa, Istanbul, Turkey
1 shared publication - Ayşe Sanem Şahlı
Hacettepe Üniversitesi Sağlık Hizmetleri MYO, İşitme Konuşma Eğitim Ünitesi
1 shared publication - Ayşim Büge Öz
Department of Pathology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, 34098 Istanbul, Türkiye
1 shared publication B Guciz Dogan
Department of Public Health, Hacettepe University Faculty of Medicine , Ankara, Turkey
1 shared publicationBahar Güçiz Doğan
Hacettepe Univ, Fac Med, Dept Publ Hlth, Ankara, Turkiye
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, e129
Establishing influenza epidemic thresholds and intensity levels in Türkiye using the moving epidemic method and assessing concordance with WHO transmission zones: A sentinel surveillance analysis of ten seasons, 2013–2025
The Moving Epidemic Method (MEM) is the ECDC/WHO-Europe-endorsed approach for establishing influenza epidemic thresholds and intensity levels, yet no positivity-based MEM analysis exists for Türkiye or any country in the WHO Western Asia transmission zone. Weekly influenza positivity rates from FluNet sentinel surveillance were analysed for ten of twelve seasons (2013/2014–2024/2025, excluding two COVID-19 pandemic seasons) using the mem R package with cross-validated optimized slope parameter, and Türkiye’s average epidemic curve and thresholds were compared with the Western Asia (excluding Türkiye) and South West Europe zones using Lin’s concordance correlation coefficient (CCC), root mean square deviation (RMSD) and complementary correlation metrics. The epidemic threshold was 10.59% positivity, with intensity thresholds at 42.56% (medium), 60.92% (high), and 71.38% (very high); cross-validated sensitivity was 0.77, specificity 0.88, and Matthews correlation coefficient 0.65. Türkiye’s average curve showed higher concordance with Western Asia (CCC=0.890; RMSD=4.22 percentage points) than South West Europe (CCC=0.672; RMSD=12.48) despite similar Pearson correlations (0.922 vs. 0.939), and the Western Asia epidemic threshold (11.50%) closely matched Türkiye’s. These first operational MEM thresholds for Türkiye and the first positivity-based thresholds for the Western Asia zone confirm alignment with the current WHO transmission zone classification and support integration into routine surveillance.
- 15 October 2026
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 154, e129
Open AccessEstablishing influenza epidemic thresholds and intensity levels in Türkiye using the moving epidemic method and assessing concordance with WHO transmission zones: A sentinel surveillance analysis of ten seasons, 2013–2025
The Moving Epidemic Method (MEM) is the ECDC/WHO-Europe-endorsed approach for establishing influenza epidemic thresholds and intensity levels, yet no positivity-based MEM analysis exists for Türkiye or any country in the WHO Western Asia transmission zone. Weekly influenza positivity rates from FluNet sentinel surveillance were analysed for ten of twelve seasons (2013/2014–2024/2025, excluding two COVID-19 pandemic seasons) using the mem R package with cross-validated optimized slope parameter, and Türkiye’s average epidemic curve and thresholds were compared with the Western Asia (excluding Türkiye) and South West Europe zones using Lin’s concordance correlation coefficient (CCC), root mean square deviation (RMSD) and complementary correlation metrics. The epidemic threshold was 10.59% positivity, with intensity thresholds at 42.56% (medium), 60.92% (high), and 71.38% (very high); cross-validated sensitivity was 0.77, specificity 0.88, and Matthews correlation coefficient 0.65. Türkiye’s average curve showed higher concordance with Western Asia (CCC=0.890; RMSD=4.22 percentage points) than South West Europe (CCC=0.672; RMSD=12.48) despite similar Pearson correlations (0.922 vs. 0.939), and the Western Asia epidemic threshold (11.50%) closely matched Türkiye’s. These first operational MEM thresholds for Türkiye and the first positivity-based thresholds for the Western Asia zone confirm alignment with the current WHO transmission zone classification and support integration into routine surveillance.
- Open Access
- 1 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 501
Undiagnosed visual disorders among first-grade children in Türkiye: a school-based photoscreening cross-sectional study with cost analysis
- 1 August 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1) , 501
Open AccessUndiagnosed visual disorders among first-grade children in Türkiye: a school-based photoscreening cross-sectional study with cost analysis
- Open Access
- 1 August 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1) , 1506
SALGINTR: development and early evaluation of a low-cost cloud-based digital participatory surveillance system for influenza-like Illness among physicians in Türkiye — a proof of concept
- 1 August 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1) , 1506
Open AccessSALGINTR: development and early evaluation of a low-cost cloud-based digital participatory surveillance system for influenza-like Illness among physicians in Türkiye — a proof of concept
- Open Access
- 22 June 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences
Background: Effective transition from pediatric to adult care is essential in Duchenne muscular dystrophy (DMD), but evidence on how transition is delivered in everyday practice remains limited. In Turkey, no clinical framework specifies how transition should occur, although national regulation requires completion of transfer by age 23. This study aimed to describe current practice, identify barriers and facilitators from physician and patient perspectives, and compare findings with international frameworks to inform a national guideline. Methods: As part of the AIM-DMD (National plan of action to raise Awareness and Improve Medical care of Duchenne Muscular Dystrophy) initiative, we conducted a national cross-sectional survey between June and December 2025, comprising parallel sub-studies of physicians and patients with DMD and their caregivers. Two structured online questionnaires were developed, guided by the Got Transition Six Core Elements framework and international Delphi consensus statements. The physician survey was distributed through professional networks; the patient and caregiver survey through the DMD Families Association and neuromuscular reference centers. Results: Sixty-two physicians (43 pediatric and 19 adult neurologists) from 28 cities and 48 patients and caregivers from 24 of these cities responded. Only 17.7% of physicians reported a systematic institutional transition program, 38.7% prepared individualized transition plans, and 9.7% described true readiness assessment. Joint pretransition consultations were held regularly by only 6.5% of physicians. Among transitioned patients, 72.4% first heard about transition at age 17 or later, and 62.1% considered their preparation inadequate. All physicians reported transferring medical data at transition, most commonly through institutional electronic health records (80.6%); however, 41.4% of patients and caregivers were unaware that any information had been conveyed to the adult team. Physicians, patients, and caregivers all identified the lack of a formal transition protocol, joint pediatric and adult consultations, multidisciplinary integration, and a designated coordinator role as priority areas for improvement. Conclusions: DMD transition care across Turkey lacks consistent structure. Key gaps include limited readiness assessment, delayed discussions, poor patient and caregiver awareness of the transition process, and lack of coordinated multidisciplinary structures. Our study identified common priorities raised by physicians, patients, and caregivers that need to be improved and could inform the development of standardized protocols.
- 22 June 2026
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Open AccessTransition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences
Background: Effective transition from pediatric to adult care is essential in Duchenne muscular dystrophy (DMD), but evidence on how transition is delivered in everyday practice remains limited. In Turkey, no clinical framework specifies how transition should occur, although national regulation requires completion of transfer by age 23. This study aimed to describe current practice, identify barriers and facilitators from physician and patient perspectives, and compare findings with international frameworks to inform a national guideline. Methods: As part of the AIM-DMD (National plan of action to raise Awareness and Improve Medical care of Duchenne Muscular Dystrophy) initiative, we conducted a national cross-sectional survey between June and December 2025, comprising parallel sub-studies of physicians and patients with DMD and their caregivers. Two structured online questionnaires were developed, guided by the Got Transition Six Core Elements framework and international Delphi consensus statements. The physician survey was distributed through professional networks; the patient and caregiver survey through the DMD Families Association and neuromuscular reference centers. Results: Sixty-two physicians (43 pediatric and 19 adult neurologists) from 28 cities and 48 patients and caregivers from 24 of these cities responded. Only 17.7% of physicians reported a systematic institutional transition program, 38.7% prepared individualized transition plans, and 9.7% described true readiness assessment. Joint pretransition consultations were held regularly by only 6.5% of physicians. Among transitioned patients, 72.4% first heard about transition at age 17 or later, and 62.1% considered their preparation inadequate. All physicians reported transferring medical data at transition, most commonly through institutional electronic health records (80.6%); however, 41.4% of patients and caregivers were unaware that any information had been conveyed to the adult team. Physicians, patients, and caregivers all identified the lack of a formal transition protocol, joint pediatric and adult consultations, multidisciplinary integration, and a designated coordinator role as priority areas for improvement. Conclusions: DMD transition care across Turkey lacks consistent structure. Key gaps include limited readiness assessment, delayed discussions, poor patient and caregiver awareness of the transition process, and lack of coordinated multidisciplinary structures. Our study identified common priorities raised by physicians, patients, and caregivers that need to be improved and could inform the development of standardized protocols.
- Open Access
- 20 April 2026
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 6 (2) , 17
CD34-Stained Microvessel Density and Immune Checkpoint Inhibitor Outcomes in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study
Background/Objectives: Immune checkpoint inhibitors (ICIs) improve outcomes in metastatic non-squamous non-small cell lung cancer (NSCLC), yet predictive biomarkers remain limited. This study investigated whether CD34-stained microvessel density (MVD) is associated with ICI efficacy. Methods: Patients with metastatic non-squamous NSCLC and tumor specimen suitable for anti-CD34 immunohistochemistry were included. In the derivation cohort, ROC analysis for objective response rate (ORR; CR + PR) identified a Youden-optimized threshold of 14.5 vessels/HPF (×400) (sensitivity 67%, specificity 93%; AUC 0.744, 95% CI 0.53–0.95; p = 0.021), which was applied without re-optimization to an internal validation cohort and a chemotherapy-only comparator. Results: In the derivation cohort, (n = 25), ORR was higher with MVD ≥ 14.5 than p = 0.004) and OS/TFST were longer (OS: 53.0 vs. 17.1 months, p = 0.037; TFST: 50.0 vs. 6.0 months, p = 0.014). In the validation cohort (n = 13), MVD ≥ 14.5 was associated with longer TFST (9.0 vs. 4.0 months; p = 0.035) and numerically longer OS (12.0 vs. 7.0 months; p = 0.059). As a cut-off-independent sensitivity analysis, continuous MVD (per five vessels/HPF) was associated with longer TFST (HR 0.663, 95% CI 0.454–0.969; p = 0.034). No association was observed in the chemotherapy-only cohort. Conclusions: Higher CD34-MVD may be a feasible vascular metric associated with ICI outcomes that warrants prospective validation.
- 20 April 2026
- Published by MDPI AG in International Journal of Translational Medicine
- Vol. 6 (2) , 17
Open AccessCD34-Stained Microvessel Density and Immune Checkpoint Inhibitor Outcomes in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study
Background/Objectives: Immune checkpoint inhibitors (ICIs) improve outcomes in metastatic non-squamous non-small cell lung cancer (NSCLC), yet predictive biomarkers remain limited. This study investigated whether CD34-stained microvessel density (MVD) is associated with ICI efficacy. Methods: Patients with metastatic non-squamous NSCLC and tumor specimen suitable for anti-CD34 immunohistochemistry were included. In the derivation cohort, ROC analysis for objective response rate (ORR; CR + PR) identified a Youden-optimized threshold of 14.5 vessels/HPF (×400) (sensitivity 67%, specificity 93%; AUC 0.744, 95% CI 0.53–0.95; p = 0.021), which was applied without re-optimization to an internal validation cohort and a chemotherapy-only comparator. Results: In the derivation cohort, (n = 25), ORR was higher with MVD ≥ 14.5 than p = 0.004) and OS/TFST were longer (OS: 53.0 vs. 17.1 months, p = 0.037; TFST: 50.0 vs. 6.0 months, p = 0.014). In the validation cohort (n = 13), MVD ≥ 14.5 was associated with longer TFST (9.0 vs. 4.0 months; p = 0.035) and numerically longer OS (12.0 vs. 7.0 months; p = 0.059). As a cut-off-independent sensitivity analysis, continuous MVD (per five vessels/HPF) was associated with longer TFST (HR 0.663, 95% CI 0.454–0.969; p = 0.034). No association was observed in the chemotherapy-only cohort. Conclusions: Higher CD34-MVD may be a feasible vascular metric associated with ICI outcomes that warrants prospective validation.
- 4 December 2025
- Published by Elsevier in Health Policy
- Vol. 165, 105523
Healthcare workforce distribution during multiple crises: a 12-year analysis of physician allocation, retention and equity patterns in Turkey
- 4 December 2025
- Published by Elsevier in Health Policy
- Vol. 165, 105523
Healthcare workforce distribution during multiple crises: a 12-year analysis of physician allocation, retention and equity patterns in Turkey
- 22 July 2025
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 113 (4) , 117023
The aetiologic agents and resistance rates in community-acquired complicated intra-abdominal infections: Where are we locally?
- 22 July 2025
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 113 (4) , 117023
The aetiologic agents and resistance rates in community-acquired complicated intra-abdominal infections: Where are we locally?
- Open Access
- 28 June 2025
- Published by Hacettepe University, Faculty of Economics and Administrative Sciences Department of Health Care Management in Hacettepe Sağlık İdaresi Dergisi
- Vol. 28 (2) , 263-276
SAĞLIK HİZMETLERİNE ERİŞİMDE SOSYAL YARDIMLAŞMA VE DAYANIŞMA VAKIFLARININ YEREL ETKİSİ: KESİTSEL BİR ÇALIŞMA
Türkiye’de yoksulluk sınırı altında yaşayan milyonlarca vatandaş, sağlık hizmetlerine erişimde engellerle karşılaşmaktadır. Her on vatandaştan biri tıbbi muayene veya tedavi için karşılanmamış gereksinimleri olduğunu belirtmekte, %2,3’ü ise bunun nedeninin çok pahalı olması, çok uzak olması veya uzun bekleme süresi olduğunu ifade etmektedir. Sağlık hizmetlerine erişimde ilçe düzeyinde karşılanmamış gereksinimleri ve bu ihtiyaçların sosyal yardımlarla nasıl ele alındığını tanımlamak amacıyla yapılan bu araştırmada, bir ilçe Sosyal Yardımlaşma ve Dayanışma Vakfı'na (SYDV), Şubat 2022-Şubat 2023’te sağlıkla ilgili başvurular (ulaşım, ilaç, tıbbi cihaz/sarf malzemesi yardımı) analiz edilmiştir. Başvurusu kabul edilenlerin (n=130) %83,8’inin yol yardımı için maddi destek aldığı, bunların %55’inin ise il dışında tedavi gördüğü saptanmıştır. Yardım alanların %26,9’u onkoloji hastası olup, bunların %97,1'i yol yardımı için başvuruda bulunmuştur. İl dışı tedavi için yapılan tekrarlayan başvurular, yerel sağlık hizmetlerinin yetersizliğine ve bu hastaların sık sık başka illerde tedavi almak zorunda kaldıklarına işaret etmektedir. Sosyal yardımların, bireylerin sağlık hizmetlerine erişiminde önemli bir rol oynadığı, ancak mevcut desteğin yetersiz kaldığı durumlarda cepten sağlık harcamalarının artması nedeniyle karşılanamamış sağlık ihtiyacının derinleştiği düşünülmektedir. Sağlık hizmetlerine erişimdeki maddi engeller, sağlık hizmetlerine eriştikten sonra sosyal hizmet talebi ve sağlık harcamalarında cepten ödemelerin payına yönelik araştırmalar yapılmalıdır. SYDV tarafından sunulan bu tür yardımlar, hastaların sağlık hizmetlerine erişimine katkı sunmakla birlikte, yerel düzeyde sağlık ihtiyaçlarının tam anlamıyla karşılanamadığını ve sosyal yardım programlarının daha hedeflenmiş bir şekilde düzenlenmesi gerektiğini ortaya koymaktadır.
- 28 June 2025
- Published by Hacettepe University, Faculty of Economics and Administrative Sciences Department of Health Care Management in Hacettepe Sağlık İdaresi Dergisi
- Vol. 28 (2) , 263-276
Open AccessSAĞLIK HİZMETLERİNE ERİŞİMDE SOSYAL YARDIMLAŞMA VE DAYANIŞMA VAKIFLARININ YEREL ETKİSİ: KESİTSEL BİR ÇALIŞMA
Türkiye’de yoksulluk sınırı altında yaşayan milyonlarca vatandaş, sağlık hizmetlerine erişimde engellerle karşılaşmaktadır. Her on vatandaştan biri tıbbi muayene veya tedavi için karşılanmamış gereksinimleri olduğunu belirtmekte, %2,3’ü ise bunun nedeninin çok pahalı olması, çok uzak olması veya uzun bekleme süresi olduğunu ifade etmektedir. Sağlık hizmetlerine erişimde ilçe düzeyinde karşılanmamış gereksinimleri ve bu ihtiyaçların sosyal yardımlarla nasıl ele alındığını tanımlamak amacıyla yapılan bu araştırmada, bir ilçe Sosyal Yardımlaşma ve Dayanışma Vakfı'na (SYDV), Şubat 2022-Şubat 2023’te sağlıkla ilgili başvurular (ulaşım, ilaç, tıbbi cihaz/sarf malzemesi yardımı) analiz edilmiştir. Başvurusu kabul edilenlerin (n=130) %83,8’inin yol yardımı için maddi destek aldığı, bunların %55’inin ise il dışında tedavi gördüğü saptanmıştır. Yardım alanların %26,9’u onkoloji hastası olup, bunların %97,1'i yol yardımı için başvuruda bulunmuştur. İl dışı tedavi için yapılan tekrarlayan başvurular, yerel sağlık hizmetlerinin yetersizliğine ve bu hastaların sık sık başka illerde tedavi almak zorunda kaldıklarına işaret etmektedir. Sosyal yardımların, bireylerin sağlık hizmetlerine erişiminde önemli bir rol oynadığı, ancak mevcut desteğin yetersiz kaldığı durumlarda cepten sağlık harcamalarının artması nedeniyle karşılanamamış sağlık ihtiyacının derinleştiği düşünülmektedir. Sağlık hizmetlerine erişimdeki maddi engeller, sağlık hizmetlerine eriştikten sonra sosyal hizmet talebi ve sağlık harcamalarında cepten ödemelerin payına yönelik araştırmalar yapılmalıdır. SYDV tarafından sunulan bu tür yardımlar, hastaların sağlık hizmetlerine erişimine katkı sunmakla birlikte, yerel düzeyde sağlık ihtiyaçlarının tam anlamıyla karşılanamadığını ve sosyal yardım programlarının daha hedeflenmiş bir şekilde düzenlenmesi gerektiğini ortaya koymaktadır.
- 26 May 2025
- Published by Elsevier in Health Policy
- Vol. 159, 105363
Addressing workforce gaps in public health medicine subspecialties in Turkiye: A call to action
- 26 May 2025
- Published by Elsevier in Health Policy
- Vol. 159, 105363
Addressing workforce gaps in public health medicine subspecialties in Turkiye: A call to action
- Open Access
- 30 July 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1370343
Creating, publishing, and spreading processes of health-related contents in internet news sites: evaluation of the opinions of actors in health communication
Introduction: The accuracy and reliability of health information disseminated through news is crucial, as it directly impacts both individual and societal health outcomes. This study aims to analyze the publication process of health content in Türkiye and its implications for public health. By examining the perspectives of various health communication stakeholders, the study seeks to identify existing issues and propose potential solutions.Methods: The research uses a mixed-methods approach, including baseline content analysis of 846 news by 133 criteria, quantitative research with 78 participants encompassing bureaucrats, academics, journalists, and health association members, and 15 in-depth interviews for comprehensive insights.Results: The content analysis indicated that 23.2% of the analyzed news articles lacked credible sources, while 63% did not mention the author’s name. A striking 96.2% of respondents stated that inaccurate health news poses a risk to public health, emphasizing the urgent need for standardized reporting practices. The majority (90.9%) pinpointed the media as the primary catalysts for infodemic spread, with 93.5% citing gatekeepers as barriers to accurate information. Eroding trust in media, fueled by unethical practices, harms both media credibility and effective public health interventions.Discussion: The study underscores the necessity for a collaborative approach among public institutions, academia, and media, focusing on responsibility, regulation, and sanctions against the infodemic. The research advocates for a balanced approach that prioritizes health rights and press freedom within a stakeholder-driven framework, highlighting that legislation alone cannot fully enhance the digital information ecosystem.
- 30 July 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1370343
Open AccessCreating, publishing, and spreading processes of health-related contents in internet news sites: evaluation of the opinions of actors in health communication
Introduction: The accuracy and reliability of health information disseminated through news is crucial, as it directly impacts both individual and societal health outcomes. This study aims to analyze the publication process of health content in Türkiye and its implications for public health. By examining the perspectives of various health communication stakeholders, the study seeks to identify existing issues and propose potential solutions.Methods: The research uses a mixed-methods approach, including baseline content analysis of 846 news by 133 criteria, quantitative research with 78 participants encompassing bureaucrats, academics, journalists, and health association members, and 15 in-depth interviews for comprehensive insights.Results: The content analysis indicated that 23.2% of the analyzed news articles lacked credible sources, while 63% did not mention the author’s name. A striking 96.2% of respondents stated that inaccurate health news poses a risk to public health, emphasizing the urgent need for standardized reporting practices. The majority (90.9%) pinpointed the media as the primary catalysts for infodemic spread, with 93.5% citing gatekeepers as barriers to accurate information. Eroding trust in media, fueled by unethical practices, harms both media credibility and effective public health interventions.Discussion: The study underscores the necessity for a collaborative approach among public institutions, academia, and media, focusing on responsibility, regulation, and sanctions against the infodemic. The research advocates for a balanced approach that prioritizes health rights and press freedom within a stakeholder-driven framework, highlighting that legislation alone cannot fully enhance the digital information ecosystem.